the presence of KOt-Bu, in 1,4-dioxane as a solvent, at 90–100 °C. The 8-bromobenzo[f]quinazolin-1(2H)-one 15 was synthesized via condensation of the ethyl or tert-butyl 2-amino-8-bromonaphthalene-1-carboxylate 6, 10 with formamide, followed by reaction with 3,4-dimethoxybenzyl bromide. However, the 6-bromobenzo[h]quinazolin-4(3H)-ones 19a, 19b were prepared from ethyl 4-bromo-1-[(tert-butoxycarbo
氨基和benzoquinazolinones的
硫烷基-衍
生物16A - Ç,20A - Ç和21A - ç使用bromobenzoquinazolinones
钯催化的Buchwald-Hartwig偶联反应制备下15,图19A,19B和1-取代的
哌嗪或
硫醇。Pd(OAc)2与XantPhos的组合被证明是最有效的方法,可在90-100°C的KO t -Bu存在下,在1,4-
二恶烷中作为溶剂使用。 8
溴苯并[ ˚F ]
喹唑啉-1(2 ħ) -酮15经由乙基的缩合或合成叔丁基2-
氨基-8-
溴萘-1-
甲酸叔丁酯6,10与甲酰胺中,然后用3反应,4-二甲氧基苄基
溴。然而,由4-
溴-1-[[(叔丁氧基羰基)
氨基]
萘-2-
羧酸乙酯(17)制备6-
溴苯并[ h ]
喹唑啉-4(3H)-酮19a,19b。 化合物16a,20a,20c对HT29和HCT116
细胞系的潜在细胞毒性的
生物学筛选显示,化合物20a具有显着的抗癌活性。